Peritonectomy and resection of mesentery during visceral-peritoneal debulking (VPD) in patients with stage IIIC-IV ovarian cancer: a phase I-II trial

被引：0
|
作者：
Marchetti, Matteo [1 ]
Noventa, Marco [1 ]
Spagnol, Giulia [1 ]
De Tommasi, Orazio [1 ]
Coldebella, Davide [1 ]
Tamagnini, Matteo [1 ]
Bigardi, Sofia [1 ]
Saccardi, Carlo [1 ]
Tozzi, Roberto [1 ]
机构：
[1] Univ Padua, Padua, Italy
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_1期
关键词：
D O I：
10.1136/ijgc-2024-ESGO.41
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
159
引用
收藏
页码：A34 / A34
页数：1
相关论文
共 50 条
  • [31] A phase II clinical trial of metformin as a cancer stem cell targeting agent in stage IIc/III/IV ovarian, fallopian tube, and primary peritoneal cancer.
    Buckanovich, Ronald J.
    Brown, Jason
    Shank, Jessica
    Griffith, Kent A.
    Reynolds, R. Kevin
    Johnston, Carolyn
    McLean, Karen
    Uppal, Shitanshu
    Liu, J. Rebecca
    Cabrera, Lourdes
    Mehta, Geeta
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy
    Scarfone, G
    Villa, A
    Parazzini, F
    Sciatta, C
    Polverino, G
    Bolis, G
    TUMORI, 1999, 85 (04) : 217 - 219
  • [33] A randomized, open-label, phase II study assessing the efficacy and the safety of bevacizumab in neoadjuvant therapy in patients with FIGO stage IIIc/IV ovarian, tubal, or peritoneal adenocarcinoma, initially unresectable.
    Rouzier, Roman
    Morice, Philippe
    Floquet, Anne
    Selle, Frederic
    Lamhaudie, Eric
    Fourchotte, Virginia
    Pomel, Christophe
    Fauvet, Raffaele
    Colombo, Pierre Emmanuel
    Kalbacher, Elsa
    Follana, Philippe
    Martin, Sandrino
    Losoin, Anne
    Lecuru, Fabrico
    Pautier, Patricia
    Guyon, Frederic
    Cottu, Paul H.
    Joly, Florence
    Ghazi, Youssef
    Chereau, Elisabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Phase II evaluation of neoadjuvant chemotherapy and interval debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube, or primary peritoneal cancer: A Southwest Oncology Group study
    Tiersten, A.
    Liu, P.
    Smith, H.
    Wilczynski, S.
    Robinson, W.
    Markman, M.
    Alberts, D.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S3 - S3
  • [35] A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with stage II-IV epithelial ovarian cancer following negative surgical assessment
    Barakat, RR
    Almadrones, L
    Venkatraman, ES
    Aghajanian, C
    Brown, C
    Shapiro, F
    Curtin, JP
    Spriggs, D
    GYNECOLOGIC ONCOLOGY, 1998, 69 (01) : 17 - 22
  • [36] Phase I-II trial of carboplatin (CBDCA) an vinorelbine (VNR) in stage IV non-small cell lung cancer (NSCLC).: A pilot study of Spanish Lung Cancer Group
    Massutí, B
    Barneto, I
    Meana, JA
    Herrero, J
    Picó, C
    Aranda, E
    García, MA
    de la Gándara, I
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S260 - S261
  • [37] A phase I/II trial of weekly docetaxel and gefitinib in elderly patients with stage IIIB/IV non-small cell lung cancer
    Stinchcombe, Thomas E.
    Buzkova, Petra
    Choksi, Janak
    Taylor, Mark
    Bakri, Kamal
    Gillenwater, Heidi
    Tynan, Maureen
    Mears, Andrea
    Jones, Paul E.
    Socinski, Mark A.
    LUNG CANCER, 2006, 52 (03) : 305 - 311
  • [38] Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009
    Tiersten, Amy D.
    Liu, P. Y.
    Smith, Harriet O.
    Wilczynski, Sharon R.
    Robinson, William R., III
    Markman, Maurie
    Alberts, David S.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (03) : 444 - 449
  • [39] First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial
    Wu, Xiaohua
    Liu, Jihong
    An, Ruifang
    Yin, Rutie
    Zhang, Yu
    Zhou, Huaijun
    He, Aiqin
    Wang, Li
    Zhang, Jieqing
    Liu, Ziling
    Duan, Wei
    Zhu, Jianqing
    Lou, Ge
    Chen, Guilin
    Cheng, Ying
    Xue, Fengxia
    Nick, Sonja
    Wang, Haiyan
    Li, Donghang
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (05)
  • [40] Phase I/II trial of docetaxel and carboplatin as a first-line therapy in patients with stage IV non-small-cell lung cancer
    Kataoka, Kensuke
    Suzuki, Ryujiro
    Taniguchi, Hiroyuki
    Noda, Yasunobu
    Shindoh, Joe
    Matsumoto, Syuichi
    Watanabe, Yoshiaki
    Honda, Kousuke
    Suzuki, Kiyoshi
    Baba, Kenji
    Imaizumi, Kazuyoshi
    Kume, Hiroaki
    Hasegawa, Yoshinori
    Takagi, Kenzo
    LUNG, 2006, 184 (03) : 133 - 139
12345